These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 18278839

  • 1. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.
    Qazi U, Lam C, Karumanchi SA, Petri M.
    J Rheumatol; 2008 Apr; 35(4):631-4. PubMed ID: 18278839
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N.
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
    Gurnadi JI, Mose J, Handono B, Satari MH, Anwar AD, Fauziah PN, Yogi Pramatirta A, Rihibiha DD.
    BMC Res Notes; 2015 Oct 04; 8():534. PubMed ID: 26434493
    [Abstract] [Full Text] [Related]

  • 7. Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.
    de Jesús GR, Lacerda MI, Rodrigues BC, Dos Santos FC, do Nascimento AP, Cristóvão Porto L, de Jesús NR, Levy RA, Klumb EM.
    Arthritis Care Res (Hoboken); 2021 May 04; 73(5):717-721. PubMed ID: 32583963
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec 04; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC, Thériault S, Massé J, Bujold E, Giguère Y.
    Clin Chem Lab Med; 2014 Aug 04; 52(8):1169-78. PubMed ID: 24535301
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison.
    Andersen LB, Frederiksen-Møller B, Work Havelund K, Dechend R, Jørgensen JS, Jensen BL, Nielsen J, Lykkedegn S, Barington T, Christesen HT.
    J Am Soc Hypertens; 2015 Feb 04; 9(2):86-96. PubMed ID: 25600419
    [Abstract] [Full Text] [Related]

  • 14. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA.
    J Clin Endocrinol Metab; 2005 Aug 04; 90(8):4895-903. PubMed ID: 15886253
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L, Herraìz I, Zeisler H, Schlembach D, Stepan H, Küssel L, Henrich W, Galindo A, Verlohren S.
    Ultrasound Obstet Gynecol; 2015 Mar 04; 45(3):286-93. PubMed ID: 25491901
    [Abstract] [Full Text] [Related]

  • 17. Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus.
    Mayer-Pickel K, Stern C, Eberhard K, Lang U, Obermayer-Pietsch B, Cervar-Zivkovic M.
    J Reprod Immunol; 2018 Jun 04; 127():19-23. PubMed ID: 29689494
    [Abstract] [Full Text] [Related]

  • 18. Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester.
    Chelli D, Hamdi A, Saoudi S, Jenayah AA, Zagre A, Jguerim H, Bedis C, Sfar E.
    Clin Lab; 2016 Oct 01; 62(10):1927-1932. PubMed ID: 28164532
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
    Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, Suzuki M.
    Hypertens Res; 2010 May 01; 33(5):422-7. PubMed ID: 20150910
    [Abstract] [Full Text] [Related]

  • 20. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women.
    Hanita O, Alia NN, Zaleha AM, Nor Azlin MI.
    Malays J Pathol; 2014 Apr 01; 36(1):19-26. PubMed ID: 24763231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.